நீண்டது கால பின்தொடரவும் மேலே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீண்டது கால பின்தொடரவும் மேலே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீண்டது கால பின்தொடரவும் மேலே Today - Breaking & Trending Today

Medication Adherence Intervention for Cardiovascular Disease


53 a team-based approach was used to deliver a medication adherence intervention; a group of experts from cardiology, nursing, community medicine, and fine arts developed and validated an intervention package that consisted of a booklet for nurses, a patient education booklet and flashcards for patient education. After one year of follow-up, the mean adherence scores were significantly higher in the intervention group (
p ....

Sao Paulo , Tamil Nadu , South Korea , Yazdan Panah , Heshmati Nabavi , Ali Beigloo , Sarah Szanton , J Clin Pharm , Brazj Pharm , Emami Moghadam , Behnam Vashani , Thukani Sathanantham , Multidiscip Healthc , Indianj Pharm , Joanna Briggs , Health Educ Res , Intj Community Based Nurs Midwifery , Public Health Rev , Health Care Poor Underserved , World Health Organization , Community Based Study , Health Serv Res , Veritas Health Innovation , Pharm Health Serv Res , Public Health , Long Term Therapy ,

Medtronic Receives Approval for U.S. Labeling of the Intellis Platform Showing Superior Back Pain Relief When Using DTM Spinal Cord Stimulation


Medtronic Receives Approval for U.S. Labeling of the Intellis Platform Showing Superior Back Pain Relief When Using DTM Spinal Cord Stimulation
Medtronic plc the global leader in medical technology, today announced the U.S. Food and Drug Administration has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting superior back pain relief with …
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Intellis™ Platform with Differential Target Multiplexed (DTM™) programming for the treatment of chronic, intractable back and leg pain. The new labeling will include study outcomes from a multicenter randomized control trial reflecting su ....

United States , Medtronic Intellis , Ryan Weispfenning , Las Vegas , Jeff Trauring , Exchange Commission , American Neuromodulation Society , Drug Administration , Differential Target Multiplexed , Visual Analog Scale , Charlie Covert , Pain Therapies , Neuroscience Portfolio , Controlled Clinical Trial , Treating Intractable Chronic Low Back Pain , North American Neuromodulation Society , Long Term Follow Up , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் வேகாஸ் , ஜெஃப் இழுவை , பரிமாற்றம் தரகு , காட்சி அனலாக் அளவு , சார்லி இரகசிய , வலி சிகிச்சைகள் , நரம்பியல் போர்ட்‌ஃபோலீயோ , கட்டுப்படுத்தப்படுகிறது மருத்துவ சோதனை ,